Degree of control and delayed intensification of antihyperglycaemic treatment in type 2 diabetes mellitus patients in primary care in Spain-Reference-Cited by-同舟云学术

Degree of control and delayed intensification of antihyperglycaemic treatment in type 2 diabetes mellitus patients in primary care in Spain

Published:2011-01 Issue:1 Volume:91 Page:108-114
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Conthe Pedro,Mata Manuel,Orozco Domingo,Pajuelo Francisco,Barreto Carmen Sofía,Anaya Silvia Fernández,Gomis Ramón

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference25 articles.

1. Haemoglobin A1c—a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS);Manley;Clin Chem Lab Med,2003

2. Effects of intensive glucose lowering in type 2 diabetes;Gerstein;N Engl J Med,2008

3. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes;Patel;N Engl J Med,2008

4. American Diabetes Association (ADA): Standards of medical care in diabetes—2009. Diabetes Care 2009:32(Suppl. 1): S13–S61.

5. NICE (National Institute for Health and Clinical Excellence). Clinical guideline CG87. Type 2 diabetes: the management of type 2 diabetes (partial update may 2009) Disponible en: http://guidance.nice.org.uk/CG87/NiceGuidance/pdf/English (last access november 27th 2009).

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kardiovaskuläres Risikomanagement bei Typ-2 Diabetes: Werden Menschen mit Typ-2 Diabetes in der diabetologischen Schwerpunktpraxis kardiovaskulär risikoadjustiert behandelt?;Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen;2021-12

2. Analysis of the effectiveness of second oral glucose-lowering therapy in routine clinical practice from the mediterranean area: A retrospective cohort study;Diabetes Research and Clinical Practice;2021-01

3. Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs;BMC Health Services Research;2020-08-26

4. In guidelines physicians trust? Physician perspective on adherence to medical guidelines for type 2 diabetes mellitus;Heliyon;2020-08

5. Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses;Expert Review of Pharmacoeconomics & Outcomes Research;2020-07-20